Expression of Full Length PRCV ISU-1 Spike Protein

SK Sarah Keep
BC Brigid Veronica Carr
FL Fabian Z. X. Lean
AF Albert Fones
JN Joseph Newman
GD Giulia Dowgier
GF Graham Freimanis
EV Eleni Vatzia
NP Noemi Polo
HE Holly Everest
IW Isobel Webb
AM Adam Mcnee
BP Basu Paudyal
NT Nazia Thakur
AN Alejandro Nunez
RM Ronan MacLoughlin
HM Helena Maier
JH John Hammond
DB Dalan Bailey
RW Ryan Waters
BC Bryan Charleston
TT Toby Tuthill
PB Paul Britton
EB Erica Bickerton
ET Elma Tchilian
request Request a Protocol
ask Ask a question
Favorite

The spike sequence from PRCV ISU-1 (GenBank Accession number: DQ811787.1) was modified to replace the coding region for the C-terminal transmembrane and cytoplasmic domains, with a T4 foldon trimerization domain followed by a His8 tag. The sequence coding for amino acids E914 and L915 was mutated to two prolines in an attempt to stabilise the spike in a pre-fusion state similar to that described for other coronavirus spikes. The sequence was optimised to human codons and synthesised into the plasmid expression vector pTwist CMV BetaGlobin, to create vector pPRCV-ISU1-PP-Foldon. The spike was expressed in Expi293F cells (ThermoFisher) according to the manufacturer’s instructions. Culture supernatants were clarified by centrifugation and purified through 5 mL HisTrap FF column (GE Healthcare). Fractions containing spike were concentrated and the excess imidazole removed by using buffer exchange columns (Zeba, Merck).

Search protocols in the Bio-protocol database

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A